Nano & Microfluidics Keynote Speakers

Andrew J deMello Professor of Biochemical Engineering & Institute Chair, ETH Zürich Andrew is currently Professor of Biochemical Engineering in the Department of Chemistry & Applied Biosciences at ETH Zürich, and until October 2020 was Head of the Institute for Chemical and Bioengineering. Prior to his arrival in Zurich, he was Professor of Chemical Nanosciences and Head of the Nanostructured Materials and Devices Section in the Chemistry Department at Imperial College London. His research interests cover a broad range of activities in the broad areas of microfluidics and nanoscale science. Primary specializations include the development of microfluidic devices for high-throughput biological and chemical analysis, ultra-sensitive optical spectroscopies, microfluidic tools for material synthesis and clinical diagnostic technologies.
Abraham Lee Professor, University of California Irvine Abraham (Abe) P. Lee is Professor of Biomedical Engineering (BME) and Mechanical and Aerospace Engineering (MAE) at the University of California, Irvine. He is Director of the NSF I/UCRC “Center for Advanced Design & Manufacturing of Integrated Microfluidics” (CADMIM). Currently Dr. Lee serves as Editor-in-Chief for the Lab on a Chip journal. Prior to UCI, he was a program manager in the Microsystems Technology Office at DARPA (1999-2001) and a group leader with Lawrence Livermore National Lab. Over the years, Dr. Lee has pioneered research in applying microfluidics to biomedical applications, and currently focuses on integrated microfluidic systems for precision medicine. His research has contributed to the founding of several start-up companies. He owns 45 issued US patents and is author of over 100 journals articles. Professor Lee was awarded the 2009 Pioneers of Miniaturization Prize and is an elected fellow of the NAI, AIMBE, RSC, ASME, and BMES.
Jean-Louis Viovy Group Leader, Institut Curie Our interdisciplinary group is dedicated to the application of physics and chemistry to biology and medicine. It has three main lines of research. The first is the development of bioanalytical tools and methods. The group was a pioneer in microfluidics and lab on chips, developing in the area innovative technologies: magnetic and convective self-assembly, flow control, non-conventional microfabrication strategies and surface treatments, high throughput droplet microfluidics. Using these technologies, the group is developing several diagnosis-oriented projects in collaboration with clinicians, e.g.: - Development of new media and strategies for mutation analysis (now in use in routine in several hospitals in France). - Capture and molecular typing of tumour cells from patients, for the evaluation of metastatic relapse and treatment orientation. The group is coordinator of the European Project CaMiNEMS on this topic, and collaborating with several hospitals and research groups in France and abroad. It is also involved in cooperative programs with clinicans (INCA DHOS) - Early diagnosis of neurodegenerative diseases (prion diseases, Alzheimer) by microfluidic methods, within the European consortium NADINE - Original systems for the oriented culture of neurones, and the study of neurons degenerescence (ANR project NEUROSCREEN, ""Plan Alzeimer"" project ""Neurochip"") - Portable “point of care” microfluidic device for fast genetic analysis of pathogens, and the diagnosis of nosocomial infections (ANR project “REDLOC)